Filed 2mo ago· Mar 10, 2026
13 days to disclose
Markwayne Mullin
RSenateOklahoma
↑bought
UnitedHealth Group
UNH
$50K-$100K
+39.9% vs S&P 500
Trade dateFeb 25, 2026
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.





































| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Mar 10, 2026 2mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | UnitedHealth Group UNH | Feb 25, 2026 13 days to disclose | Good buy·+$25.5K+34.0% +39.9% vs S&P 500 | $50K-$100K midpoint $75K |
Mar 2, 2026 3mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | McKesson MCK | Feb 4, 2026 26 days to disclose | Bad buy·−$3.2K-10.0% −5.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 4, 2026 3mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | McKesson MCK | Jan 5, 2026 30 days to disclose | Bad buy·−$3.3K-10.3% −6.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 4, 2026 3mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | McKesson MCK | Jan 5, 2026 30 days to disclose | Bad buy·−$3.3K-10.3% −6.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 16, 2026 4mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Elevance Health ELV Elevance Health, Inc. | Dec 29, 2025 18 days to disclose | Good buy·+$4K+12.4% +17.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 16, 2026 4mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Boston Scientific BSX | Dec 29, 2025 18 days to disclose | Bad buy·−$16.2K-49.9% −45.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 16, 2026 4mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | IQVIA Holdings IQV IQVIA Holdings, Inc. | Dec 29, 2025 18 days to disclose | Bad buy·−$7.3K-22.5% −17.8% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 16, 2026 4mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Intuitive Surgical ISRG Intuitive Surgical, Inc. - | Dec 29, 2025 18 days to disclose | Bad buy·−$9.8K-30.2% −25.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 1, 2025 8mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | iShares U.S. Health Care Providers ETF IHF | Sep 24, 2025 7 days to disclose | price pending | $15K-$50K midpoint $32.5K |
Oct 1, 2025 8mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | UnitedHealth Group UNH | Sep 24, 2025 7 days to disclose | Good buy·+$2.7K+8.3% −0.6% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 1, 2025 8mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Intuitive Surgical ISRG Intuitive Surgical, Inc. - | Sep 24, 2025 7 days to disclose | Bad buy·−$7.1K-9.5% −18.4% vs S&P 500 | $50K-$100K midpoint $75K |
Aug 18, 2025 9mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | UnitedHealth Group UNH | Aug 1, 2025 17 days to disclose | Flat·+0.0% +13.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Aug 12, 2025 9mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | Insulet PODD | Jan 4, 2024 586 days to disclose · 541 past 45-day window | Smart sell·+$410+5.1% +57.9% vs S&P 500 | $1K-$15K midpoint $8K |
Aug 12, 2025 9mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | Insulet PODD | Dec 22, 2023 599 days to disclose · 554 past 45-day window | Smart sell·+$985+12.3% +63.0% vs S&P 500 | $1K-$15K midpoint $8K |
Jul 30, 2025 10mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Insulet PODD | Jan 3, 2023 939 days to disclose · 894 past 45-day window | Bad buy·−$2.7K-33.8% −121.3% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 11, 2025 11mo ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Thermo Fisher Scientific TMO | May 13, 2025 29 days to disclose | Good buy·+$3.3K+10.2% −2.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
May 12, 2025 1.1y ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | Thermo Fisher Scientific TMO | Apr 8, 2025 34 days to disclose | Flat·+0.0% +11.7% vs S&P 500 | $50K-$100K midpoint $75K |
Feb 27, 2025 1.3y ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | Danaher DHR | Feb 13, 2025 14 days to disclose | Flat·+0.0% +1.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Feb 27, 2025 1.3y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | IQVIA Holdings IQV | Feb 13, 2025 14 days to disclose | Bad buy·−$3.3K-10.2% −11.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 31, 2025 1.3y ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | Abbott Laboratories ABT | Jan 8, 2025 23 days to disclose | Flat·+0.0% +5.8% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 31, 2024 1.4y ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | Abbott Laboratories ABT | Dec 11, 2024 20 days to disclose | Flat·+0.0% +4.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 19, 2024 1.7y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | IQVIA Holdings IQV | Aug 20, 2024 30 days to disclose | Bad buy·−$11.1K-34.3% −62.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Sep 19, 2024 1.7y ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | Edwards Lifesciences EW | Aug 20, 2024 30 days to disclose | Missed gain·−$6.9K-21.3% +6.5% vs S&P 500 | $15K-$50K midpoint $32.5K |
Jan 26, 2024 2.4y ago | ![]() Markwayne Mullin RSenateOklahoma | ↓sold | Insulet PODD | Dec 22, 2023 35 days to disclose | Smart sell·+$985+12.3% +63.0% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | UnitedHealth Group UNH | Oct 3, 2023 29 days to disclose | Bad buy·−$2K-25.2% −41.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Edwards Lifesciences EW | Oct 3, 2023 29 days to disclose | Good buy·+$1.7K+20.9% −48.4% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Boston Scientific BSX | Oct 3, 2023 29 days to disclose | Good buy·+$1.6K+20.4% −48.9% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Elevance Health ELV Elevance Health, Inc. | Oct 3, 2023 29 days to disclose | Bad buy·−$1.6K-20.5% −89.8% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Abbott Laboratories ABT | Oct 3, 2023 29 days to disclose | Bad buy·−$389-4.9% −74.2% vs S&P 500 | $1K-$15K midpoint $8K |
Nov 1, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Thermo Fisher Scientific TMO | Oct 3, 2023 29 days to disclose | Bad buy·−$1.7K-5.4% −21.9% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Thermo Fisher Scientific TMO | Sep 13, 2023 29 days to disclose | Bad buy·−$2.4K-7.4% −19.3% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | UnitedHealth Group UNH | Sep 13, 2023 29 days to disclose | Bad buy·−$6.7K-20.6% −32.4% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Abbott Laboratories ABT | Sep 13, 2023 29 days to disclose | Bad buy·−$3.7K-11.3% −71.2% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Elevance Health ELV Elevance Health, Inc. | Sep 13, 2023 29 days to disclose | Bad buy·−$7.2K-22.2% −82.1% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Boston Scientific BSX | Sep 13, 2023 29 days to disclose | Bad buy·−$3.2K-9.8% −21.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Danaher DHR | Sep 13, 2023 29 days to disclose | Bad buy·−$6.8K-20.8% −80.7% vs S&P 500 | $15K-$50K midpoint $32.5K |
Oct 12, 2023 2.6y ago | ![]() Markwayne Mullin RSenateOklahoma | ↑bought | Edwards Lifesciences EW | Sep 13, 2023 29 days to disclose | Good buy·+$4.9K+15.0% −44.9% vs S&P 500 | $15K-$50K midpoint $32.5K |